Explore the complete record of transactions filed by 정인수, Directeur. Insider active across 2 companies, notably 아이엠바이오로직스. Cumulatively, 17,943 disclosures have been published. Activity tracked since 4 March 2026. The latest transaction was filed on 4 March 2026 (Purchase). Regulator: DART (FSS). All data is free.
Jeong In-soo is an executive director at IM Biologics, where he oversees the company's operations and strategies. With a strong background in the sector, he is responsible for implementing initiatives aimed at fostering innovation and growth. His leadership is essential in guiding IM Biologics towards a prosperous future.